Follow
Dawn Swan
Dawn Swan
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Venous thromboembolism in multiple myeloma–choice of prophylaxis, role of direct oral anticoagulants and special considerations
D Swan, A Rocci, C Bradbury, J Thachil
British Journal of Haematology 183 (4), 538-556, 2018
592018
Thrombosis in immune thrombocytopenia—current status and future perspectives
D Swan, A Newland, F Rodeghiero, J Thachil
British journal of haematology 194 (5), 822-834, 2021
412021
Beyond DNA damage: exploring the immunomodulatory effects of cyclophosphamide in multiple myeloma
D Swan, M Gurney, J Krawczyk, AE Ryan, M O’Dwyer
Hemasphere 4 (2), e350, 2020
352020
The problem of under-diagnosis and over-diagnosis of pulmonary embolism
D Swan, S Hitchen, FA Klok, J Thachil
Thrombosis research 177, 122-129, 2019
222019
Management of bleeding and procedures in patients on antiplatelet therapy
D Swan, N Loughran, M Makris, J Thachil
Blood Reviews 39, 100619, 2020
192020
Current and emerging immunotherapeutic approaches to the treatment of multiple myeloma
D Swan, K Lynch, M Gurney, M O’Dwyer
Therapeutic advances in hematology 10, 2040620719854171, 2019
192019
The evolving status of immunotherapies in multiple myeloma: The future role of bispecific antibodies
D Swan, D Routledge, S Harrison
British Journal of Haematology 196 (3), 488-506, 2022
162022
The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal …
S Sarkar, SKS Chauhan, J Daly, A Natoni, H Fairfield, R Henderson, ...
Cancer Immunology, Immunotherapy 69, 421-434, 2020
162020
Bispecific antibodies in multiple myeloma: opportunities to enhance efficacy and improve safety
D Swan, P Murphy, S Glavey, J Quinn
Cancers 15 (6), 1819, 2023
152023
Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular …
SD Naicker, CL Feerick, K Lynch, D Swan, C McEllistrim, R Henderson, ...
Oncoimmunology 10 (1), 1859263, 2021
142021
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation …
D Swan, PJ Hayden, DJ Eikema, L Koster, S Sauer, D Blaise, E Nicholson, ...
British Journal of Haematology 197 (1), 82-96, 2022
112022
Heparin–Messias or Verschlimmbesserung?
D Swan, M Carrier, T Lisman, J Thachil
Journal of Thrombosis and Haemostasis 19 (10), 2373-2382, 2021
102021
Successful venetoclax salvage in the setting of refractory, dialysis-dependent multiple myeloma with t (11; 14)
D Swan, C Delaney, A Natoni, M O’Dwyer, J Krawczyk
haematologica 105 (3), e141, 2020
102020
Port removal in patients receiving emicizumab prophylaxis: A single centre experience and review of the literature
D Swan, S Paran, B Nolan
Haemophilia 28 (1), 42-45, 2022
82022
Non‐factor therapies for bleeding disorders: A primer for the general haematologist
D Swan, J Mahlangu, J Thachil
EJHaem 3 (3), 584-595, 2022
72022
Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: a review of cases and current practices
D Swan, H Enright, R Desmond, G Le, E El Hassadi, B Hennessy, F Lynott, ...
Thrombosis Update 5, 100086, 2021
72021
A review of anticoagulation in patients with central nervous system malignancy: between a rock and a hard place
D Swan, DJ Seiffge, J Thachil
Journal of neurology 268 (7), 2390-2401, 2021
52021
Reintroduction of anticoagulant therapy after intracranial haemorrhage: If and when?
M Scott, R Low, D Swan, J Thachil
Blood Reviews 32 (3), 256-263, 2018
52018
Practical management of the haemorrhagic complications of myeloproliferative neoplasms
E Jones, B Dillon, D Swan, J Thachil
British Journal of Haematology 199 (3), 313-321, 2022
42022
Thromboprophylaxis in COVID-19–Rationale and considerations
S Bristogiannis, D Swan, J Thachil
Advances in Biological Regulation 81, 100819, 2021
42021
The system can't perform the operation now. Try again later.
Articles 1–20